Xeno Acharya is the Founder & CEO of Datum, a health and biomedical data platform focused on developing AI agents from validated clinical evidence, emphasizing accuracy, transparency, and explainability. Previously, Xeno served as Lead Product Manager at Minimum and held the position of Senior AI Product Manager at Frontiers, where oversight of quality assurance and algorithm development for numerous publications was a key responsibility. Xeno's extensive experience also includes leadership roles in ZAVA, Doti Health, and PHIN, contributing to telemedicine solutions, healthcare transparency, and data-driven insights. Earlier career positions at PA Consulting, Babylon Health, Aetion, Inc., and a research fellowship at the London School of Hygiene & Tropical Medicine further established Xeno as a specialist in healthcare AI, epidemiology, and health services. Xeno's educational background includes advanced studies in Epidemiology & Biostatistics at Harvard, a Master's in Health Services Administration from the University of Washington, and a Bachelor's in Biology from Reed College.
Sign up to view 1 direct report
Get started